| 标题 |
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Zhou Q; Chen M; Jiang O; Pan Y; Hu D; et al 出版日期:2022/02/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)